Table 2.
Study Participants' Characteristics and Laboratory Data
| |
|
Intervention group |
|
|---|---|---|---|
| Parameter | Nonoverweight group | Baseline | 12 months |
| Weight (kg) |
65.7±2.1*** |
101.2±2.5 |
94.9±2.7### |
| BMI (kg/m2) |
22.2±0.4*** |
33.9±0.7 |
31.5±0.7### |
| Systolic blood pressure (mmHg) |
114.1±1.7 |
118.6±1.7 |
117.3±1.7 |
| Diastolic blood pressure (mmHg) |
68.7±1.2 |
69.0±1.1 |
68.5±1.2 |
| Fat mass (kg) |
15.1±1.07*** |
41.7±1.5 |
36.6±1.6### |
| TSH (ng/dL) |
1.8±0.16 |
2.2±0.2 |
1.9±0.2 |
| Free T4 (ng/dL) |
1.24±0.50** |
1.12±0.02 |
1.09±0.03 |
| Total T3 (ng/dL) |
100.6±3.1** |
112.7±3.1 |
101.8±2.6### |
| Reverse T3 (ng/mL) |
0.33±0.03* |
0.26±0.01 |
0.26±0.01 |
| Leptin (ng/dL) |
9.3±2.2*** |
39.1±3.6 |
34.5±3.4 |
| REE (kcal/24 h) | 1307.5±46.9*** | 1634.5±47.8 | 1612.9±43.1 |
Data are expressed as mean±SEM.
Comparison between control and intervention group at baseline: *p<0.05; **p<0.01; ***p<0.001.
Comparison between baseline and 12 months: #p≤0.05; ##p<0.01; ###p<0.001.
BMI, body mass index; TSH, thyrotropin, REE, resting energy expenditure.